Chemokines in CNS injury and repair

Cell and Tissue Research

Volumn 349, Issue 1, 2012, Pages 229-248

  Jaerve, Anne ^a   Müller, Hans Werner ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Axon sprouting; Central nervous system (CNS); Chemokines; CNS injury; CNS repair; Stem cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL14 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MARAVIROC; N [2 [[1 [4 (1,3 BENZODIOXOL 5 YL) 4 HYDROXYCYCLOHEXYL] 4 ETHOXY 3 PYRROLIDINYL]AMINO] 2 OXOETHYL] 3 (TRIFLUOROMETHYL)BENZAMIDE; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

AGING; BINDING AFFINITY; BRAIN INFARCTION SIZE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHROMOSOMAL LOCALIZATION; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; UPREGULATION;

CENTRAL NERVOUS SYSTEM; CHEMOKINES; HUMANS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84862776272     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1427-3     Document Type: Review

References (199)

1. Adachi K, Yimin Y, Satake K, Matsuyama Y, Ishiguro N, Sawada M, Hirata Y, Kiuchi K (2005) Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. Neurosci Res 51:73-80 (Pubitemid 39642882)
2. Ahmad AS, Ahmad M, Brum-Fernandes AJ de, Dore S (2005) Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 1066:71-77 (Pubitemid 41790730)
3. Ahmad AS, Saleem S, Ahmad M, Dore S (2006a) Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 89:265-270 (Pubitemid 43013774)
4. Ahmad M, Saleem S, Zhuang H, Ahmad AS, Echeverria V, Sapirstein A, Dore S (2006b) 1-HydroxyPGE reduces infarction volume in mouse transient cerebral ischemia. Eur J Neurosci 23:35-42
5. Al-Turkmani MR, Freedman SD, Laposata M (2007) Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 77:309-318 (Pubitemid 350198866)
6. Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2:410-416
7. Andreasson K (2010) Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91:104-112
8. Antonopoulou G, Barbayianni E, Magrioti V, Cotton N, Stephens D, Constantinou-Kokotou V, Dennis EA, Kokotos G (2008) Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes. Bioorg Med Chem 16:10257-10269 (Pubitemid 50322653)
9. Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E (2010) The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. Neurobiol Dis 38:304-312
10. Bartholdi D, Schwab ME (1997) Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 9:1422-1438 (Pubitemid 27303243)
11. Bate C, Kempster S, Williams A (2006) Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. Neuropharmacology 50:229-237 (Pubitemid 43100008)
12. Beck G, Sugiura Y, Shinzawa K, Kato S, Setou M, Tsujimoto Y, Sakoda S, Sumi-Akamaru H (2011) Neuroaxonal dystrophy in calcium-independent phospholipase A2beta deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci 31:11411-11420
13. Beuckmann CT, Lazarus M, Gerashchenko D, Mizoguchi A, Nomura S, Mohri I, Uesugi A, Kaneko T, Mizuno N, Hayaishi O, Urade Y (2000) Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J Comp Neurol 428:62-78
14. Bilak M, Wu L, Wang Q, Haughey N, Conant K, St Hillaire C, Andreasson K (2004) PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56:240-248 (Pubitemid 39037919)
15. Blakemore WF, Eames RA, Smith KJ, McDonald WI (1977) Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 33:31-43 (Pubitemid 8143186)
16. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, Sapirstein A (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390:622-625 (Pubitemid 28016198)
17. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690 (Pubitemid 32385902)
18. Brown WJ, Chambers K, Doody A (2003) Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 4:214-221 (Pubitemid 36665382)
19. Capper EA, Marshall LA (2001) Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 40:167-197 (Pubitemid 32223465)
20. Caughey GE, Pouliot M, Cleland LG, James MJ (1997) Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol 158:351-358 (Pubitemid 127483876)
21. Chang HW, Kudo I, Tomita M, Inoue K (1987) Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat. J Biochem 102:147-154
22. Chen GY, Nunez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826-837
23. Chernenko GA, Barrowman JA, Kean KT, Herzberg GR, Keough KM (1989) Intestinal absorption and lymphatic transport of fish oil (MaxEPA) in the rat. Biochim Biophys Acta 1004:95-102 (Pubitemid 19178619)
24. Cohen JA, Chun J (2011) Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann Neurol 69:759-777
25. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752-758 (Pubitemid 43085841)
26. David S, Ousman SS (2002) Recruiting the immune response to promote axon regeneration in the injured spinal cord. Neuroscientist 8:33-41 (Pubitemid 34101816)
27. David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388-399
28. David S, Lacroix S (2003) Molecular approaches to spinal cord repair. Annu Rev Neurosci 26:411-440 (Pubitemid 37064940)
29. De S, Trigueros MA, Kalyvas A, David S (2003) Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci 24:753-765 (Pubitemid 37506017)
30. Dennis EA (1994) Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269:13057-13060
31. Dennis EA (1997) The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 22:1-2
32. Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK (2002) Peroxisome proliferatoractivated receptor-gamma agonist 15-deoxy-delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J Immunol 168:2508-2515 (Pubitemid 34171857)
33. Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK (2004) Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J Neuroimmunol 148:116-126 (Pubitemid 38229564)
34. Donnelly DJ, Popovich PG (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209:378-388 (Pubitemid 351181428)
35. Endres S, Schacky C von (1996) n-3 Polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 7:48-52 (Pubitemid 26109132)
36. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577-599 (Pubitemid 46633316)
37. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812 (Pubitemid 3006324)
38. Forst S, Weiss J, Elsbach P, Maraganore JM, Reardon I, Heinrikson RL (1986) Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate. Biochemistry 25:8381-8385 (Pubitemid 17003936)
39. Foster CA, Mechtcheriakova D, Storch MK, Balatoni B, Howard LM, Bornancin F, Wlachos A, Sobanov J, Kinnunen A, Baumruker T (2009) FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 19:254-266
40. Fredman G, Serhan CN (2011) Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 437:185-197
41. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG (1999) A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA 96:13995-14000
42. Fu Q, Hue J, Li S (2007) Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci 27:4154-4164 (Pubitemid 46597154)
43. Funk CD, Chen XS, Johnson EN, Zhao L (2002) Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat 68-69:303-312 (Pubitemid 35247403)
44. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, Watanabe M, Guaza C, Di Marzo V, Molina-Holgado E (2009) The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 33:57-71
45. Genovese T, Rossi A, Mazzon E, Di Paola R, Muia C, Caminiti R, Bramanti P, Sautebin L, Cuzzocrea S (2008) Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol 153:568-582 (Pubitemid 351199011)
46. Genovese T, Mazzon E, Rossi A, Di Paola R, Cannavo G, Muia C, Crisafulli C, Bramanti P, Sautebin L, Cuzzocrea S (2005) Involvement of 5-lipoxygenase in spinal cord injury. J Neuroimmunol 166:55-64 (Pubitemid 41074657)
47. Glaser KB, Mobilio D, Chang JY, Senko N (1993) Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci 14:92-98
48. Goodarzi K, Goodarzi M, Tager AM, Luster AD, Andrian UH von (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4:965-973 (Pubitemid 37265917)
49. Goppelt-Struebe M, Rehfeldt W (1992) Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity. Biochim Biophys Acta 1127:163-167
50. Guilbault C, De Sanctis JB, Wojewodka G, Saeed Z, Lachance C, Skinner TA, Vilela RM, Kubow S, Lands LC, Hajduch M, Matouk E, Radzioch D (2008) Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol 38:47-56
51. Guilbault C, Wojewodka G, Saeed Z, Hajduch M, Matouk E, De Sanctis JB, Radzioch D (2009) Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. Am J Respir Cell Mol Biol 41:100-106
52. Hains BC, Yucra JA, Hulsebosch CE (2001) Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J Neurotrauma 18:409-423 (Pubitemid 32336547)
53. Hall SM, Gregson NA (1971) The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J Cell Sci 9:769-789
54. Hanasaki K (1995) CD22: a cell adhesion molecule that displays alpha 2- 6-linked sialic acid-binding lectin activity. Seikagaku 67:1040-1047
55. Hanasaki K, Yokota Y, Ishizaki J, Itoh T, Arita H (1997) Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J Biol Chem 272:32792-32797 (Pubitemid 28023612)
56. Harada N, Taoka Y, Okajima K (2006) Role of prostacyclin in the development of compression trauma-induced spinal cord injury in rats. J Neurotrauma 23:1739-1749 (Pubitemid 46034448)
57. Hata AN, Breyer RM (2004) Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103:147-166 (Pubitemid 39209041)
58. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9:1512-1519 (Pubitemid 44862659)
59. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seventransmembrane receptor CRTH2. J Exp Med 193:255-261 (Pubitemid 32524457)
60. Hirashima Y, Farooqui AA, Mills JS, Horrocks LA (1992) Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol. J Neurochem 59:708-714
61. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestley JV, Michael-Titus AT (2007) A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130:3004-3019 (Pubitemid 350033967)
62. Huang W, Bhavsar A, Ward RE, Hall JC, Priestley JV, Michael-Titus AT (2009) Arachidonyl trifluoromethyl ketone is neuroprotective after spinal cord injury. J Neurotrauma 26:1429-1434
63. Hulkower KI, Hope WC, Chen T, Anderson CM, Coffey JW, Morgan DW (1992) Interleukin-1 beta stimulates cytosolic phospholipase A2 in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 184:712-718
64. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98:1294-1299 (Pubitemid 32121226)
65. Ikeda-Matsuo Y, Ota A, Fukada T, Uematsu S, Akira S, Sasaki Y (2006) Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci USA 103:11790-11795 (Pubitemid 44182529)
66. Ishii S, Nagase T, Shimizu T (2002) Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 68-69:599-609 (Pubitemid 35247423)
67. Jacobs TP, Shohami E, Baze W, Burgard E, Gunderson C, Hallenbeck J, Feuerstein G (1987) Thromboxane and 5-HETE increase after experimental spinal cord injury in rabbits. Cent Nerv Syst Trauma 4:95-118
68. Jiang C, Ting AT, Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86 (Pubitemid 28079219)
69. Jin J, Shie FS, Liu J, Wang Y, Davis J, Schantz AM, Montine KS, Montine TJ, Zhang J (2007) Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. J Neuroinflammation 4:2
70. Kalyvas A, David S (2004) Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41:323-335 (Pubitemid 38221038)
71. Kalyvas A, Baskakis C, Magrioti V, Constantinou-Kokotou V, Stephens D, López-Vales R, Lu JQ, Yong VW, Dennis EA, Kokotos G, David S (2009) Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain 132:1221-1235
72. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, Kunz A, Cho S, Orio M, Iadecola C (2006) Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12:225-229 (Pubitemid 43214750)
73. Kempski O, Shohami E, von Lubitz D, Hallenbeck JM, Feuerstein G (1987) Postischemic production of eicosanoids in gerbil brain. Stroke 18:111-119 (Pubitemid 17016695)
74. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, Tang C, Rancourt DE, Cromlish WA (1995) A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 270:22378-22385
75. Kerkela R, Boucher M, Zaka R, Gao E, Harris D, Piuhola J, Song J, Serpi R, Woulfe KC, Cheung JY, O'Leary E, Bonventre JV, Force T (2011) Cytosolic phospholipase A(2)alpha protects against ischemia/reperfusion injury in the heart. Clin Transl Sci 4:236-242
76. Kerr BJ, Girolami EI, Ghasemlou N, Jeong SY, David S (2008) The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. Glia 56:436-448 (Pubitemid 351212952)
77. Kihara Y, Ishii S, Kita Y, Toda A, Shimada A, Shimizu T (2005) Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J Exp Med 202:853-863 (Pubitemid 41345973)
78. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672-4680 (Pubitemid 44315368)
79. Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV (1998) Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637 (Pubitemid 28531277)
80. Kojima F, Kapoor M, Yang L, Fleishaker EL, Ward MR, Monrad SU, Kottangada PC, Pace CQ, Clark JA, Woodward JG, Crofford LJ (2008) Defective generation of a humoral immune response is associated with a reduced incidence and severity of collageninduced arthritis in microsomal prostaglandin E synthase-1 null mice. J Immunol 180:8361-8368
81. Kostenis E, Ulven T (2006) Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 12:148-158
82. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P (2011) Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32:157-164
83. Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JE, Kingston HM, Rosser EM, Wassmer E, Gissen P, Maher ER (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology 70:1623-1629 (Pubitemid 351620319)
84. Lambeau G, Gelb MH (2008) Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 77:495-520
85. Lambeau G, Lazdunski M (1999) Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol Sci 20:162-170
86. Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C (2003) Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg 38:564-575 (Pubitemid 41123225)
87. Larsen PH, Wells JE, Stallcup WB, Opdenakker G, Yong VW (2003) Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23:11127-11135 (Pubitemid 37548948)
88. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G, Wesselborg S (2003) Apoptotic cells induce migration of phagocytes via caspase-3- mediated release of a lipid attraction signal. Cell 113:717-730 (Pubitemid 36724936)
89. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ 2nd (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129:1627-1631 (Pubitemid 12031103)
90. Li J, Liang X, Wang Q, Breyer RM, McCullough L, Andreasson K (2008) Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Neurosci Lett 438:210-215
91. Liang X, Wang Q, Hand T, Wu L, Breyer RM, Montine TJ, Andreasson K (2005) Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci 25:10180-10187 (Pubitemid 41636214)
92. Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, Andreasson K (2008) The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol 64:304-314
93. Lim SN, Huang W, Hall JC, Ward RE, Priestley JV, Michael-Titus AT (2010) The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot Essent Fatty Acids 83:193-201
94. Lin LL, Lin AY, DeWitt DL (1992) Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem 267:23451-23454 (Pubitemid 23088136)
95. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278 (Pubitemid 23044941)
96. Liu D, Wu L, Breyer R, Mattson MP, Andreasson K (2005) Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 57:758-761 (Pubitemid 40628868)
97. Liu NK, Zhang YP, Titsworth WL, Jiang X, Han S, Lu PH, Shields CB, Xu XM (2006) A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 59:606-619
98. Locati M, Zhou D, Luini W, Evangelista V, Mantovani A, Sozzani S (1994) Rapid induction of arachidonic acid release by monocyte chemotactic protein-1 and related chemokines. Role of Ca2+ influx, synergism with platelet-activating factor and significance for chemotaxis. J Biol Chem 269:4746-4753
99. López-Vales R, Garcia-Alias G, Guzman-Lenis MS, Fores J, Casas C, Navarro X, Verdu E (2006) Effects of COX-2 and iNOS inhibitors alone or in combination with olfactory ensheathing cell grafts after spinal cord injury. Spine 31(Phila Pa 1976):1100-1106
100. López-Vales R, Navarro X, Shimizu T, Baskakis C, Kokotos G, Constantinou-Kokotou V, Stephens D, Dennis EA, David S (2008) Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain 131:2620-2631
101. López-Vales R, Redensek A, Skinner TA, Rathore KI, Ghasemlou N, Wojewodka G, DeSanctis J, Radzioch D, David S (2010) Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J Neurosci 30:3220-3226
102. López-Vales R, Ghasemlou N, Redensek A, Kerr BJ, Barbayianni E, Antonopoulou G, Baskakis C, Rathore KI, Constantinou-Kokotou V, Stephens D, Shimizu T, Dennis EA, Kokotos G, David S (2011) Phospholipase A2 superfamily members play divergent roles after spinal cord injury. FASEB J 25:4240-4252
103. Ma W, Quirion R (2008) Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett 437:165-169
104. Makwana M, Raivich G (2005) Molecular mechanisms in successful peripheral regeneration. FEBS J 272:2628-2638 (Pubitemid 40825411)
105. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278:43807-43817 (Pubitemid 37346009)
106. Marusic S, Leach MW, Pelker JW, Azoitei ML, Uozumi N, Cui J, Shen MW, DeClercq CM, Miyashiro JS, Carito BA, Thakker P, Simmons DL, Leonard JP, Shimizu T, Clark JD (2005) Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med 202:841-851 (Pubitemid 41345972)
107. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S (2000) Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013-2017
108. McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16:R551-R560 (Pubitemid 44066793)
109. McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24:257-268 (Pubitemid 38181690)
110. McKerracher L, David S (2004) Easing the brakes on spinal cord repair. Nat Med 10:1052-1053 (Pubitemid 39424864)
111. Mitsuhashi T, Ikata T, Morimoto K, Tonai T, Katoh S (1994) Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries. Paraplegia 32:524-530 (Pubitemid 24241456)
112. Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M (2003) Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia 42:263-274
113. Mohri I, Taniike M, Taniguchi H, Kanekiyo T, Aritake K, Inui T, Fukumoto N, Eguchi N, Kushi A, Sasai H, Kanaoka Y, Ozono K, Narumiya S, Suzuki K, Urade Y (2006) Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 26:4383-4393
114. Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M (2007) Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol 66:469-480 (Pubitemid 46869689)
115. Molloy GY, Rattray M, Williams RJ (1998) Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci Lett 258:139-142 (Pubitemid 29023567)
116. Montine TJ, Milatovic D, Gupta RC, Valyi-Nagy T, Morrow JD, Breyer RM (2002) Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 83:463-470 (Pubitemid 35191411)
117. Moreland DB, Soloniuk DS, Feldman MJ (1989) Leukotrienes in experimental spinal cord injury. Surg Neurol 31:277-280 (Pubitemid 19089563)
118. Murakami M, Kudo I (2001) Diversity and regulatory functions of mammalian secretory phospholipase A2s. Adv Immunol 77:163-194 (Pubitemid 33703706)
119. Murakami M, Kudo I, Inoue K (1993) Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem 268:839-844 (Pubitemid 23019711)
120. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I (1997) Regulatory functions of phospholipase A2. Crit Rev Immunol 17:225-283
121. Murakami M, Nakatani Y, Tanioka T, Kudo I (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 68-69:383-399 (Pubitemid 35247409)
122. Murakami M, Taketomi Y, Miki Y, Sato H, Hirabayashi T, Yamamoto K (2011) Recent progress in phospholipase A research: from cells to animals to humans. Prog Lipid Res 50:152-192
123. Nishisho T, Tonai T, Tamura Y, Ikata T (1996) Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. Neurosurgery 39:950-956
124. Nordvik I, Myhr KM, Nyland H, Bjerve KS (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102:143-149 (Pubitemid 30645133)
125. Oikawa Y, Yamato E, Tashiro F, Yamamoto M, Uozumi N, Shimada A, Shimizu T, Miyazaki J (2005) Protective role for cytosolic phospholipase A2alpha in autoimmune diabetes of mice. FEBS Lett 579:3975-3978 (Pubitemid 40961898)
126. Ousman SS, David S (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104 (Pubitemid 30172156)
127. Ousman SS, David S (2001) MIP-1alpha, MCP-1, GM-CSF, and TNFalpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21:4649-4656 (Pubitemid 32565623)
128. Owada Y, Tominaga T, Yoshimoto T, Kondo H (1994) Molecular cloning of rat cDNA for cytosolic phospholipase A2 and the increased gene expression in the dentate gyrus following transient forebrain ischemia. Brain Res Mol Brain Res 25:364-368 (Pubitemid 24266089)
129. Owens T, Wekerle H, Antel J (2001) Genetic models for CNS inflammation. Nat Med 7:161-166 (Pubitemid 32148481)
130. Pereira MP, Hurtado O, Cardenas A, Bosca L, Castillo J, Davalos A, Vivancos J, Serena J, Lorenzo P, Lizasoain I, Moro MA (2006) Rosiglitazone and 15-deoxy-delta12, 14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26:218-229 (Pubitemid 43151578)
131. Perrin FE, Lacroix S, Aviles-Trigueros M, David S (2005) Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 128:854-866 (Pubitemid 40516922)
132. Piccinini AM, Midwood KS (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010:pii:672395
133. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500:267-285 (Pubitemid 44937122)
134. Rapoport SI, Chang MC, Spector AA (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42:678-685 (Pubitemid 32507167)
135. Redensek A, Rathore KI, Berard JL, López-Vales R, Swayne LA, Bennett SA, Mohri I, Taniike M, Urade Y, David S (2011) Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury. Glia 59:603-614
136. Resnick DK, Graham SH, Dixon CE, Marion DW (1998) Role of cyclooxygenase 2 in acute spinal cord injury. JNeurotrauma 15:1005-1013 (Pubitemid 28560043)
137. Resnick DK, Nguyen P, Cechvala CF (2001a) Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. Spine J 1:432-436 (Pubitemid 33378114)
138. Resnick DK, Nguyen P, Cechvala CF (2001b) Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury. Spine J 1:437-441 (Pubitemid 33378115)
139. Ribotta MG, Provencher J, Feraboli-Lohnherr D, Rossignol S, Privat A, Orsal D (2000) Activation of locomotion in adult chronic spinal rats is achieved by transplantation of embryonic raphe cells reinnervating a precise lumbar level. J Neurosci 20:5144-5152 (Pubitemid 30421717)
140. Rocha PN, Plumb TJ, Coffman TM (2003) Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin Immunopathol 25:215-227
141. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403:103-108 (Pubitemid 30038530)
142. Rouault M, Le Calvez C, Boilard E, Surrel F, Singer A, Ghomashchi F, Bezzine S, Scarzello S, Bollinger J, Gelb MH, Lambeau G (2007) Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 46:1647-1662
143. Ryborg AK, Deleuran B, Thestrup-Pedersen K, Kragballe K (1994) Lysophosphatidylcholine: a chemoattractant to human T lymphocytes. Arch Dermatol Res 286:462-465 (Pubitemid 24324722)
144. Ryborg AK, Deleuran B, Sogaard H, Kragballe K (2000) Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Derm Venereol 80:242-246
145. Saeed Z, Guilbault C, De Sanctis JB, Henri J, Marion D, St-Arnaud R, Radzioch D (2007) Fenretinide prevents the development of osteoporosis in Cftr-KO mice. J Cyst Fibros 7:222-230 (Pubitemid 351650269)
146. Saegusa J, Akakura N, Wu CY, Hoogland C, Ma Z, Lam KS, Liu FT, Takada YK, Takada Y (2008) Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem 283:26107-26115
147. Saito M, Ueno M, Kubo K, Yamaguchi M (1998) Dose-response effect of dietary docosahexaenoic acid on fatty acid profiles of serum and tissue lipids in rats. J Agric Food Chem 46:184-193 (Pubitemid 128488042)
148. Saiwai H, Ohkawa Y, Yamada H, Kumamaru H, Harada A, Okano H, Yokomizo T, Iwamoto Y, Okada S (2010) The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am J Pathol 176:2352-2366
149. Saleem S, Kim YT, Maruyama T, Narumiya S, Dore S (2009) Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. J Neuroimmunol 208:87-93
150. Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B, Cisse M, Scearce-Levie K, Cheng IH, Gan L, Palop JJ, Bonventre JV, Mucke L (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 11:1311-1318
151. Sarne Y, Asaf F, Fishbein M, Gafni M, Keren O (2011) The dual neuroprotective-neurotoxic profile of cannabinoid drugs. Br J Pharmacol 163:1391-1401
152. Sarsilmaz M, Songur A, Ozyurt H, Kus I, Ozen OA, Ozyurt B, Sogut S, Akyol O (2003) Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 69:253-259 (Pubitemid 37463806)
153. Saruhashi Y, Young W, Perkins R (1996) The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Exp Neurol 139:203-213 (Pubitemid 26228089)
154. Schaloske RH, Dennis EA (2006) The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246-1259 (Pubitemid 44755364)
155. Schwab JM, Serhan CN (2006) Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6:414-420
156. Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ (2000a) Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 111:122-130
157. Schwab JM, Nguyen TD, Postler E, Meyermann R, Schluesener HJ (2000b) Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia. Acta Neuropathol 99:609-614 (Pubitemid 30307369)
158. Schwab JM, Seid K, Schluesener HJ (2001) Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats. J Neurotrauma 18:881-890 (Pubitemid 32852889)
159. Schwab JM, Beschorner R, Meyermann R, Gozalan F, Schluesener HJ (2002) Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. J Neurosurg 96:892-899 (Pubitemid 34415404)
160. Schwab JM, Conrad S, Elbert T, Trautmann K, Meyermann R, Schluesener HJ (2004) Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury. Glia 47:377-386 (Pubitemid 39295421)
161. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869-874 (Pubitemid 46920139)
162. Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25:101-137
163. Serhan CN, Yacoubian S, Yang R (2008a) Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3:279-312 (Pubitemid 351488283)
164. Serhan CN, Chiang N, Van Dyke TE (2008b) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361 (Pubitemid 351595216)
165. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206:15-23
166. Serhan CN, Fredman G, Yang R, Karamnov S, Belayev LS, Bazan NG, Zhu M, Winkler JW, Petasis NA (2011) Novel proresolving aspirin-triggered DHA pathway. Chem Biol 18:976-987
167. Shinzawa K, Sumi H, Ikawa M, Matsuoka Y, Okabe M, Sakoda S, Tsujimoto Y (2008) Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci 28:2212-2220 (Pubitemid 351317640)
168. Siegal T, Shohami E, Shapira Y, Siegal T (1988) Indomethacin and dexamethasone treatment in experimental neoplastic spinal cord compression. Part 2. Effect on edema and prostaglandin synthesis. Neurosurgery 22:334-339 (Pubitemid 18076683)
169. Sobrado M, Pereira MP, Ballesteros I, Hurtado O, Fernandez-Lopez D, Pradillo JM, Caso JR, Vivancos J, Nombela F, Serena J, Lizasoain I, Moro MA (2009) Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci 29:3875-3884
170. Spite M, Serhan CN (2010) Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107:1170-1184
171. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK (2000) 15-Deoxydelta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97:4844-4849 (Pubitemid 30238645)
172. Strokin M, Sergeeva M, Reiser G (2003) Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol 139:1014-1022 (Pubitemid 36877400)
173. Sun GY, Xu J, Jensen MD, Yu S, Wood WG, Gonzalez FA, Simonyi A, Sun AY, Weisman GA (2005) Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G proteincoupled receptor agonists. Mol Neurobiol 31:27-41 (Pubitemid 41271192)
174. Tabuchi S, Uozumi N, Ishii S, Shimizu Y, Watanabe T, Shimizu T (2003) Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. Acta Neurochir Suppl 86:169-172
175. Tager AM, Luster AD (2003) BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids 69:123-134
176. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4:982-990 (Pubitemid 37265919)
177. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T (2002) Prostaglandin E (2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 317:61-64 (Pubitemid 34038006)
178. Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K (2004) Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 316:1009-1014 (Pubitemid 38369053)
179. Titsworth WL, Onifer SM, Liu NK, Xu XM (2007) Focal phospholipases A2 group III injections induce cervical white matter injury and functional deficits with delayed recovery concomitant with Schwann cell remyelination. Exp Neurol 207:150-162 (Pubitemid 47337095)
180. Titsworth WL, Cheng X, Ke Y, Deng L, Burckardt KA, Pendleton C, Liu NK, Shao H, Cao QL, Xu XM (2009) Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death. Glia 57:1521-1537
181. Ueda H (2011) Lysophosphatidic acid as the initiator of neuropathic pain. Biol Pharm Bull 34:1154-1158
182. Ujihara M, Urade Y, Eguchi N, Hayashi H, Ikai K, Hayaishi O (1988) Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. Arch Biochem Biophys 260:521-531 (Pubitemid 18058306)
183. Urade Y, Ujihara M, Horiguchi Y, Ikai K, Hayaishi O (1989) The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J Immunol 143:2982-2989 (Pubitemid 19281848)
184. Urade Y, Ujihara M, Horiguchi Y, Igarashi M, Nagata A, Ikai K, Hayaishi O (1990) Mast cells contain spleen-type prostaglandin D synthetase. J Biol Chem 265:371-375
185. Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O (1993) Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 90:9070-9074 (Pubitemid 23306453)
186. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G (2000) Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem 275:7492-7496 (Pubitemid 30159644)
187. Wang X, Budel S, Baughman K, Gould G, Song KH, Strittmatter SM (2009) Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma 26:81-95
188. Ward RE, Huang W, Curran OE, Priestley JV, Michael-Titus AT (2010) Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma 27:1769-1780
189. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, Gallagher E, Venkatraman J, Meksawan K, Deinehert S, Pendergast D, Awad AB, Ramanathan M, Munschauer F, Rudick R (2005) Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 73:397-404 (Pubitemid 41375637)
190. Wright GW, Ooi CE, Weiss J, Elsbach P (1990) Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem 265:6675-6681
191. Wu L, Wang Q, Liang X, Andreasson K (2007a) Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci Lett 421:253-258 (Pubitemid 46935366)
192. Wu LJ, Vadakkan KI, Zhuo M (2007b) ATP-induced chemotaxis of microglial processes requires P2Y receptor-activated initiation of outward potassium currents. Glia 55:810-821 (Pubitemid 46787192)
193. Xing B, Li H, Wang H, Mukhopadhyay D, Fisher D, Gilpin CJ, Li S (2011) RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury. Exp Neurol 231:247-260
194. Xu JA, Hsu CY, Liu TH, Hogan EL, Perot PL Jr, Tai HH (1990) Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem 55:907-912
195. Xu XX, Rock CO, Qiu ZH, Leslie CC, Jackowski S (1994) Regulation of cytosolic phospholipase A2 phosphorylation and eicosanoid production by colony-stimulating factor 1. J Biol Chem 269:31693-31700 (Pubitemid 24379536)
196. Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN (2004) Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 29:966-971 (Pubitemid 38580232)
197. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J, Nombela F, Torres M, Burguete MC, Manzanares J, Lizasoain I, Moro MA (2011) Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 43:211-219
198. Zhang C, Bazan NG (2010) Lipid-mediated cell signaling protects against injury and neurodegeneration. J Nutr 140:858-863
199. Zhao Z, Zhang X, Zhao C, Choi J, Shi J, Song K, Turk J, Ma ZA (2010) Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation. Endocrinology 151:3038-3048